Our team

Our team

Meet our team of talented and passionate scientists ready to tackle antimicrobial resistance with us.

  • Adèle James

    Co-founder & CTO

    Linkedin

  • Alexandros Pantalis

    Co-founder & CEO

    Linkedin

  • Ilias Theodorou

    Research Scientist

    Linkedin

  • Julia Burgan

    Research Scientist

    Linkedin

  • Manon Lemasson

    Research Scientist

    Linkedin

  • Marine Feyereisen

    Research Scientist

    Linkedin

  • Natalie Kuljanishvili

    Research Assistant

    Linkedin

  • Romain Sausset

    Research Scientist

    Linkedin

  • Tanya Lilia

    Laboratory Technician in the making

  • Adèle James

    Co-founder & CTO

    Linkedin

  • Alexandros Pantalis

    Co-founder & CEO

    Linkedin

  • Ilias Theodorou

    Research Scientist

    Linkedin

  • Julia Burgan

    Research Scientist

    Linkedin

  • Manon Lemasson

    Research Scientist

    Linkedin

  • Marine Feyereisen

    Research Scientist

    Linkedin

  • Natalie Kuljanishvili

    Research Assistant

    Linkedin

  • Romain Sausset

    Research Scientist

    Linkedin

  • Tanya Lilia

    Laboratory Technician in the making

Our advisors

  • Daniel de Vos

    Research Manager

    Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, world leader in human phage therapy.

  • Geoffroy Dubus

    Partner at Demeter

    Major European player in venture capital, private equity and infrastructure for the energy and ecological transition, ​​Demeter manages €1.2bn and has completed 200 investments since its creation in 2005.

  • Pierre Belichard

    Founder and CEO of Enterome

    Enterome is a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on their unique ability to decode the gut microbiome’s interaction with the immune system. Enterome raised €116M to date.

  • Rob Kniaz

    Partner at Hoxton Ventures

    Early-stage venture capital firm investing in disruptive tech start-ups throughout Europe, Hoxton Ventures partners with founders seeking to invent new market categories or transform large, existing industries and accelerates their global expansion.

  • Daniel de Vos

    Research Manager

    Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, world leader in human phage therapy.

  • Geoffroy Dubus

    Partner at Demeter

    Major European player in venture capital, private equity and infrastructure for the energy and ecological transition, ​​Demeter manages €1.2bn and has completed 200 investments since its creation in 2005.

  • Pierre Belichard

    Founder and CEO of Enterome

    Enterome is a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on their unique ability to decode the gut microbiome’s interaction with the immune system. Enterome raised €116M to date.

  • Rob Kniaz

    Partner at Hoxton Ventures

    Early-stage venture capital firm investing in disruptive tech start-ups throughout Europe, Hoxton Ventures partners with founders seeking to invent new market categories or transform large, existing industries and accelerates their global expansion.